Recent Updates
Recently added Catalysts
LXRX

Lexicon Appoints Ivan H. Cheung to Board of Directors

Key Takeaway: Lexicon Appoints Ivan H. Cheung to Board of Directors
Price reaction · baseline $0.8809 (2024-11-19 close) · hit after-hours · 2 other LXRX headline(s) in the window, move may be shared
day 0 close
-8.3%
day 1 · peak
-12.4%
day 3
-7.7%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus

Full Press Release Details

Lexicon Appoints Ivan H. Cheung to Board of Directors.
Last updated: Nov 20, 2024